Multi‐model averaging improves the performance of model‐guided infliximab dosing in patients with inflammatory bowel diseases

Infliximab dosage de‐escalation without prior knowledge of drug concentrations may put patients at risk for underexposure and trigger the loss of response. A single‐model approach for model‐informed precision dosing during infliximab maintenance therapy has proven its clinical benefit in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kantasiripitak, Wannee, Outtier, An, Wicha, Sebastian G., Kensert, Alexander, Wang, Zhigang, Sabino, João, Vermeire, Séverine, Thomas, Debby, Ferrante, Marc, Dreesen, Erwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381887/
https://www.ncbi.nlm.nih.gov/pubmed/35706358
http://dx.doi.org/10.1002/psp4.12813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381887/
https://www.ncbi.nlm.nih.gov/pubmed/35706358
http://dx.doi.org/10.1002/psp4.12813

Ejemplares similares